Full Press Release Details
Tiziana Life Sciences LTD
Notice of Annual General Meeting of Shareholders
To be held via video and telephonic conference
on December 29, 2022 at 9.00 a.m. (EST); 2.00pm (U.K.)
YOU ARE NOTIFIED that the 2022 annual general
meeting ("2022 AGM") of Tiziana Life Sciences LTD (the "Company") will be held via video and
telephonic conference (in accordance with the Company's bye-law 26.1) on December 29, 2022 at 9.00 a.m. (EST); 2.00pm (U.K.) or
as soon thereafter as is practicable for the purpose of transacting the following business:
Record Date: The record date for qualification
of shareholders to participate and vote in the AGM has been set for the end of trading on November 30, 2022.
Attending the Meeting: All shareholders
are invited to participate in the AGM. The electronic system for remote participation will be available for access from 8.45 a.m. (EST);
1.45 p.m. (UK) on December 29, 2022.
To join the meeting type (or paste) the following
web address into your web browser:
The password to join the meeting is "welcome"
The Webinar number is: 2599 535 5714
If you wish you may join by phone
+1-650-479-3208 United States Toll
If joining by phone use the access code: 259 953
Further guidance and instructions are available
by emailing: info@tizianalifesciences.com.
Voting: We encourage you to vote as
promptly as possible by mailing your completed and signed proxy card. Please follow the directions on your proxy card. You may also vote
during the meeting, the chairman of the meeting shall direct you on how you may cast your vote on a show of hands.
By Order of the Board
Chief Financial Officer
Dated 5 December 2022
Proposed Resolutions
Set out below is a description of each proposed
resolution for which shareholder approval is sought at the 2022 AGM. The Board of Directors (the "Board") consider
that the proposed resolutions described in this letter are in the best interests of the Company and therefore of the shareholders as a
whole, and recommend shareholders vote in favor of all.
Willy Simon, who was elected as a Class III director
at the annual general meeting of the Company held in 2021 to serve until December 31, 2022, offers himself for re-election as Class III
director until the annual general meeting to be held in 2025 or until his successor is elected. Please see below the biographical details
Willy Simon is a banker and worked
at Kredietbank N.V. and Citibank London before serving as an executive member of the Board of Generale Bank NL from 1997 to 1999 and as
the chief executive of Fortis Investment Management from 1999 to 2002. He acted as chairman of Bank Oyens & van Eeghen from 2002 to
2004. From 2004 until 2012, he served as a non-executive director of Redi & Partners Ltd., a fund of funds. He was previously chairman
of AIM-traded Velox3 plc (formerly 24/7 Gaming Group Holdings plc) until 2015 and had been a director of Playlogic Entertainment Inc.,
a NASDAQ OTC listed company.
Committee Memberships: Member of the Audit,
Risk and Disclosure Committee, the Nomination Committee and chair of the Remuneration Committee.
A copy of the Company's financial statements
for the fiscal year ended on 31 December 2021, along with the auditor's report have been made available to shareholders on the Investors
page of the Company's website at: https://www.tizianalifesciences.com/.
If you require a printed copy of our financial
statements to be mailed to you, please e-mail info@tizianalifesciences.com to submit your request.
The Board proposes that shareholders appoint PKF
LittleJohn LLP as the Company's independent auditor for fiscal year 2022.
The shareholders shall vote whether or not to
delegate to the Board the responsibility for determining the remuneration of the auditors.